- Home
- PFE vs GS Comparison
PFE vs GS Comparison
Compare PFE & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- GS
- Stock Information
- Founded
- PFE 1849
- GS 1869
- Country
- PFE United States
- GS United States
- Employees
- PFE N/A
- GS N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- GS Investment Bankers/Brokers/Service
- Sector
- PFE Health Care
- GS Finance
- Exchange
- PFE Nasdaq
- GS Nasdaq
- Market Cap
- PFE 166.8B
- GS 182.7B
- IPO Year
- PFE N/A
- GS 1999
- Fundamental
- Price
- PFE $26.37
- GS $566.21
- Analyst Decision
- PFE Buy
- GS Buy
- Analyst Count
- PFE 14
- GS 17
- Target Price
- PFE $32.31
- GS $559.75
- AVG Volume (30 Days)
- PFE 45.2M
- GS 2.1M
- Earning Date
- PFE 01-28-2025
- GS 01-15-2025
- Dividend Yield
- PFE 6.53%
- GS 2.12%
- EPS Growth
- PFE N/A
- GS 64.86
- EPS
- PFE 0.74
- GS 34.06
- Revenue
- PFE $59,375,000,000.00
- GS $49,387,000,000.00
- Revenue This Year
- PFE $8.74
- GS $17.81
- Revenue Next Year
- PFE $0.38
- GS $5.55
- P/E Ratio
- PFE $35.23
- GS $16.62
- Revenue Growth
- PFE N/A
- GS 11.97
- 52 Week Low
- PFE $24.48
- GS $372.07
- 52 Week High
- PFE $31.54
- GS $612.73
- Technical
- Relative Strength Index (RSI)
- PFE 53.13
- GS 43.60
- Support Level
- PFE $25.58
- GS $544.49
- Resistance Level
- PFE $26.52
- GS $596.32
- Average True Range (ATR)
- PFE 0.54
- GS 11.93
- MACD
- PFE 0.16
- GS -6.71
- Stochastic Oscillator
- PFE 89.73
- GS 32.45
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.